TILL TRANSAKTIONER
Mat & dryck | Hälsovård

Naturex SA has acquired Swedish Oat Fiber AB

Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.

Naturex sources, manufactures and markets natural specialty ingredients for the food, healthcare and cosmetic industries. Headquartered in Avignon, France, the group has experienced steadily increasing growth throughout the last 25 years. Naturex employs 1,700 people worldwide and had revenues of US$437 million in 2016.

Swedish Oat Fiber is a manufacturer with a key international position as a producer of oat beta-glucans dietary fibers, oat oils and oat proteins for the food industry, nutraceutical, cosmetic and animal feed applications. The company has 25 employees and an annual turnover of US$13.2 million.

Oaklins' teams in France and Sweden identified potential targets and advised the buyer on this transaction. This is another example of the strength of Oaklins' teams working together.

Parter

Prata med transaktionsteamet

Philippe Hermant

Senior Advisor
Paris, Frankrike
Oaklins France

Adel Koubaa

Managing Partner
Stockholm, Sverige
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sverige
Oaklins Sweden

Relaterade transaktioner

UKAT Group has acquired Bayberry Limited
Riskkapital | Hälsovård

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Lär dig mer
Medicija has acquired Saulės Šeimos Medicinos Centras
Hälsovård

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Lär dig mer
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Hälsovård

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Lär dig mer